Bridgeway Capital Management, LLC Century Therapeutics, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.24 Billion
- Q4 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 249,700 shares of IPSC stock, worth $182,281. This represents 0.01% of its overall portfolio holdings.
Number of Shares
249,700
Previous 257,600
3.07%
Holding current value
$182,281
Previous $440,000
42.73%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding IPSC
# of Institutions
71Shares Held
33.6MCall Options Held
9.7KPut Options Held
1.5K-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$3.95 Million1.48% of portfolio
-
Casdin Capital, LLC New York, NY5.19MShares$3.79 Million0.45% of portfolio
-
Vr Adviser, LLC New York, NY3.96MShares$2.89 Million0.66% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$2.11 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$1.74 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $43M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...